These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 16454716

  • 1. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression.
    Sundell IB, Koka PS.
    Curr HIV Res; 2006 Jan; 4(1):107-16. PubMed ID: 16454716
    [Abstract] [Full Text] [Related]

  • 2. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
    Harker LA, Marzec UM, Hunt P, Kelly AB, Tomer A, Cheung E, Hanson SR, Stead RB.
    Blood; 1996 Jul 15; 88(2):511-21. PubMed ID: 8695799
    [Abstract] [Full Text] [Related]

  • 3. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.
    Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB.
    Blood; 1998 Jun 15; 91(12):4427-33. PubMed ID: 9616135
    [Abstract] [Full Text] [Related]

  • 4. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients.
    Cole JL, Marzec UM, Gunthel CJ, Karpatkin S, Worford L, Sundell IB, Lennox JL, Nichol JL, Harker LA.
    Blood; 1998 May 01; 91(9):3239-46. PubMed ID: 9558379
    [Abstract] [Full Text] [Related]

  • 5. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U, Morita H, Torii Y, Kuwaki T, Shimizu E, Akahori H, Kato T, Miyazaki H.
    Thromb Haemost; 2001 Jan 01; 85(1):152-9. PubMed ID: 11204567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW.
    Science; 1994 Sep 02; 265(5177):1445-7. PubMed ID: 8073287
    [Abstract] [Full Text] [Related]

  • 10. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB.
    Blood; 1997 Jan 01; 89(1):155-65. PubMed ID: 8978288
    [Abstract] [Full Text] [Related]

  • 11. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
    Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller GA, de Sauvage FJ.
    Blood; 1997 Nov 01; 90(9):3423-9. PubMed ID: 9345025
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
    Hofmann WK, Ottmann OG, Hoelzer D.
    Leukemia; 1999 Apr 01; 13 Suppl 1():S14-8. PubMed ID: 10232362
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombopoietin in vitro and in vivo.
    Alexander WS, Begley CG.
    Cytokines Cell Mol Ther; 1998 Mar 01; 4(1):25-34. PubMed ID: 9557214
    [Abstract] [Full Text] [Related]

  • 17. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin.
    Ballmaier M, Schulze H, Strauss G, Cherkaoui K, Wittner N, Lynen S, Wolters S, Bogenberger J, Welte K.
    Blood; 1997 Jul 15; 90(2):612-9. PubMed ID: 9226161
    [Abstract] [Full Text] [Related]

  • 18. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.
    Scheding S, Bergmann M, Shimosaka A, Wolff P, Driessen C, Rathke G, Jaschonek K, Brugger W, Kanz L.
    Transfusion; 2002 Mar 15; 42(3):321-7. PubMed ID: 11961237
    [Abstract] [Full Text] [Related]

  • 19. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.
    Li J, Xia Y, Kuter DJ.
    Br J Haematol; 1999 Aug 15; 106(2):345-56. PubMed ID: 10460590
    [Abstract] [Full Text] [Related]

  • 20. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
    Li J, Xia Y, Kuter DJ.
    Br J Haematol; 2000 Dec 15; 111(3):943-53. PubMed ID: 11122159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.